Teraforce Technology Corp. v. Vista Controls, Inc. (In Re Teraforce Technology Corp.)

379 B.R. 626, 2007 Bankr. LEXIS 3799, 2007 WL 3377441
CourtUnited States Bankruptcy Court, N.D. Texas
DecidedNovember 13, 2007
Docket19-30038
StatusPublished
Cited by1 cases

This text of 379 B.R. 626 (Teraforce Technology Corp. v. Vista Controls, Inc. (In Re Teraforce Technology Corp.)) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, N.D. Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Teraforce Technology Corp. v. Vista Controls, Inc. (In Re Teraforce Technology Corp.), 379 B.R. 626, 2007 Bankr. LEXIS 3799, 2007 WL 3377441 (Tex. 2007).

Opinion

MEMORANDUM OPINION AND ORDER

BARBARA J. HOUSER, Bankruptcy Judge.

Before the Court is a Motion for Judgment on the Pleadings (the “Motion”) brought by defendants Vista Controls, Inc. and Curtiss-Wright Controls, Inc. The Court has jurisdiction to decide the Motion pursuant to 28 U.S.C. §§ 1334 and 157.

To decide the Motion, the Court must answer the following questions under North Carolina law: (i) can a “non-outsider” to a contract, as defined by the North Carolina Supreme Court, be held liable in tort for interfering with that contract; and, if so, (ii) can a “non-outsider” who uses improper means when interfering with a contract be held liable for tortious interference even though that person had a legitimate business interest in the contract? For the reasons explained more fully below, the Court answers both questions in the affirmative and denies the Motion.

I. Factual Background

The plaintiffs in this adversary proceeding are Teraforce Technology Corporation (“Teraforce”) and DNA Computing Solutions, Inc. (“DNA,” with Teraforce, the “Plaintiff’). 1 DNA is a wholly owned subsidiary of Teraforce. 2 Plaintiffs First Amended Complaint and Objections to Claim, Docket No. 49, (the “Amended Complaint”) at ¶ 10. The defendants are Vista Controls, Inc. (“Vista”) and Curtiss-Wright Controls, Inc. (“Curtiss-Wright,” with Vista, the “Defendants”). Vista is a wholly owned subsidiary of Curtiss-Wright. Defendants’ Memorandum in Support of Motion for Judgment on the Pleadings, Docket No. 33, (the “Memorandum”) at p. 2.

In deciding the Motion, the Court must accept the Plaintiffs factual allegations as true. 3 Accordingly, all of the “facts” set forth below are taken from the allegations contained in the Amended Complaint.

*631 Before it filed bankruptcy, DNA designed, developed, produced, and sold high-density, high-capacity embedded computing platforms and systems. Amended Complaint at ¶ 13. DNA specialized in digital signal processing (“DSP”) applications for radar, sonar, software radio, electronic warfare, and signal intelligence (the “DNA Technology”) Id. at ¶ 14. The DNA Technology was geared toward benign en vironments — ie., it could not withstand extreme temperatures or stresses. Id. Vista was in the business of “ruggedizing” circuit boards to withstand various adverse conditions. Id. at ¶ 15. In 2008, Curtiss-Wright and DNA discussed the possibility of using Vista’s methods to ruggedize DNA’s technology. Id. at ¶21. The resulting circuit card assemblies would be able to withstand adverse conditions and would be suitable for use in military and aerospace contexts. Id. at ¶ 18. As a result of their discussions, DNA and Cur-tiss-Wright executed a memorandum of understanding. Id. at ¶ 21. Pursuant to that memorandum of understanding, DNA and Vista executed a Technology License and Marketing Agreement (the “Licensing Agreement”), a Distribution Agreement (the “Distribution Agreement”), and a Technology Transfer and Support Agreement (the “Support Agreement”) (collectively, the “Agreements” or the “Vista Agreements”). Id.

Under the Licensing Agreement, DNA granted a license to use the DNA Technology to Vista and Vista promised to use that technology to develop several finalized products (the “Combined Products”). Id. at ¶ 22. Vista was to retain all rights to the Combined Products, but would grant DNA a sublicense in the products and underlying technology. Id. at ¶ 23. The Licensing Agreement required both DNA and Vista to market, advertise, and sell the Combined Products. Id. at ¶24. Vista did not pay DNA any cash consideration for the DNA technology. Id. Rather, DNA was to receive a portion of the consideration paid by third parties for each Combined Product. Id. Thus, the consideration DNA received for the DNA Technology was Vista’s promise to produce, advertise, market, and sell the Combined Products, and to share proceeds from those sales with DNA. Id.

Initially, the Combined Products were being developed according to plan. Id. at ¶ 29. But, Vista then failed to complete a final product prototype. Id. at ¶ 31. Vista informed DNA that Curtiss-Wright would not authorize additional funding for the Combined Products unless DNA obtained firm orders. Id. at ¶ 32. As per industry practice, however, DNA would not be able to solicit orders successfully without a working prototype. Icl. at ¶ 33. Further, Vista informed DNA that even if the Combined Products were completed, Vista would not market or sell them. Id. at ¶ 35. In brief, Curtiss-Wright had decided to “kill” the Combined Products so as to protect its investments in a direct competitor of DNA, leaving DNA to liquidate and disappear. Id. at ¶ 36.

Shortly after Vista and DNA entered into the Agreements, Curtiss-Wright bought all of the stock of DY4, Inc. (“DY4”). Id. at ¶ 37. DY4 was a direct competitor with DNA in the market for non-rubberized DSP products. Id. at ¶ 38. After acquiring DY4, Curtiss-Wright created Curtiss-Wright Controls Embedded Computing (“CWCEC”), an unincorporated entity, and gave it responsibility for controlling and managing Vista. Id. at ¶ 40. Curtiss-Wright placed top managers of DY4 in the leadership of CWCEC, thus allowing Vista to be controlled by DNA’s competitor. Id.

Curtiss-Wright realized that Vista’s performance under the Agreements would *632 jeopardize Curtiss-Wright and DY4 because (i) the Combined Products competed directly with DY4; (ii) Curtiss-Wright would be required to share profits on the sale of Combined Products with DNA, whereas it would retain the whole profit from sales of products by DY4; (iii) Vista’s performance under the Agreements would provide profits to DNA and would thus prop up a competitor of DY4; and (iv) DNA would use its profits to develop its next generation of products. Id. at ¶43. Further, Curtiss-Wright knew that if Vista’s failure to perform under the Agreements became obvious to DNA, DNA would terminate the Agreements, sue Vista, and take the DNA Technology to a new partner. Id. at ¶ 45.

To prevent these adverse results, Cur-tiss-Wright decided that (i) Vista would not actively market the Combined Products, id. at ¶ 46; (ii) Curtiss-Wright would cause DNA to think that Vista was continuing to develop the Combined Products when in fact Vista was not doing so, id.; and (iii) Curtiss-Wright would wait for DNA to declare bankruptcy and then turn over the DNA Technology to DY4, id. at ¶ 48.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
379 B.R. 626, 2007 Bankr. LEXIS 3799, 2007 WL 3377441, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teraforce-technology-corp-v-vista-controls-inc-in-re-teraforce-txnb-2007.